| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |